A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
Clinical trial NCT05436834 · COMPLETED
Trial details
- NCT number
- NCT05436834
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2025-10-20
- Enrollment
- 1807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.